Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
ConflictofInterest
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Articles
Vol 35,2026 No.3
The title
The title
The keywords
The author
New Online
Vol 35,2026
Vol 34,2025
Vol 33,2024
Vol 32,2023
No.3
No.2
No.1
Contents
Vol 35,2026 No.3
Date of publication: March 15, 2026
Get cover
Get contents
Prev
Vol 35,2026 No.2
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (15): key points and examples of propensity score analysis
HU Yuanhui
DIAO Sha
BO Zhenyan
ZOU Kun
ZENG Linan
LI Hai-long
ZHANG Lingli
2026,35(3):241-251
Pharmacoepidemiology
Methodology
Guidelines
Propensity score
Details
Download
Mobile
Treatment persistence of denosumab therapy and fracture risk in patients with osteoporosis: a real-world study
ZHANG Shuo
FAN Yuqing
XUE Mengyao
YAO Dongning
2026,35(3):252-260
Osteoporosis
Denosumab
Persistence treatment
Fracture
Real-world study
Details
Download
Mobile
Construction and verification of a nomogram model for the risk of acute kidney injury in patients treated with vancomycin combined with piperacillin/tazobactam or carbapenems
CHU Xiaoxiao
SHAO Huan
LI Rong
WANG Xiaodan
GUO Shaobo
2026,35(3):261-271
Vancomycin
Acute kidney injury
Nomogram
Prediction model
SHAP analysis
Drug combination
Details
Download
Mobile
Correlation between serum methylmalonic acid levels and serum neurofilament light chain
WANG Shanjie
GUO Wanlu
ZHANG Yiying
2026,35(3):272-280
Neurofilament light chain
Methylmalonic acid
Vitamin B12
Nerve injury
Details
Download
Mobile
Cost-effectiveness analysis of fondaparinux compared with low molecular-weight heparin in the treatment of recurrent spontaneous abortion
ZHU Yurong
LI Lanlan
ZHANG Rui
DAI Wei
YANG Weihu
2026,35(3):281-287
Recurrent spontaneous abortion
Fondaparinux
Low molecular-weight heparin
Cost-effectiveness analysis
Details
Download
Mobile
Multi-center drug use evaluation of Cinobufagin capsules based on weighted TOPSIS method
CAI Huiya
NAN Tingting
TAN Changli
LI Yimin
CHEN Qiongying
JIANG Chunjiao
ZHANG Jinhua
2026,35(3):288-294
Cinobufagin capsules
Drug use evaluation
Weighted TOPSIS method
Delphi method
Details
Download
Mobile
Exploring the medication rules and mechanism of action of national patent traditional Chinese medicine compound in the treatment of atrial fibrillation based on data mining, network pharmacology and molecular docking technology
WEI Mengzhao
DING Jian
GE Lan
LIU Yelu
CHENG Xiaoyu
2026,35(3):295-307
Atrial fibrillation
Traditional Chinese medicine compound
National patent
Medication rules
Mechanism of action
Data mining
Network pharmacology
Molecular docking
Details
Download
Mobile
Efficacy and safety of pregabalin in the treatment of sciatica: a systematic review and Meta-analysis
XIE Yuanyang
YIN Benjing
YE Guoyu
JI Futao
FENG Xinyue
CHEN Ge
HUANG Hongwen
YAN Lulu
XU Tianli
LIU Maoli
GU Haichao
2026,35(3):308-317
Pregabalin
Sciatica
Adverse drug event
Systematic review
Meta-analysis
Details
Download
Mobile
Efficacy of nimodipine combined with statins in the treatment of patient with subarachnoid hemorrhage and its impact on neurological function: a Meta-analysis
DU Xuebing
WANG Hongyan
ZHU Xiaodong
WU Jiajun
MA Ziyang
CAO Jing
2026,35(3):318-326
Nimodipine
Statins
Subarachnoid hemorrhage
Delayed cerebral ischemia
Meta-analysis
Details
Download
Mobile
Machine learning for predicting adverse drug events in polypharmacy: a review of methods and case studies
LONG Yujun
LIU Jianzhao
YANG Zhirong
2026,35(3):327-335
Polypharmacy
Adverse drug events
Machine learning
Graph convolutional neural network
Prediction model
Details
Download
Mobile
Applicability challenges and optimization strategies of guideline recommendations in multimorbidity management
ZHU Shuqiong
TALIFU Paerwenayi
RUAN Siyuan
GAO Feng
YOU Liangzhen
WANG Yongbo
YAN Siyu
HUANG Qiao
REN Xiangying
JIN Yinghui
2026,35(3):336-345
Multimorbidity
Clinical practice guideline
Recommendation
Real-world evidence
Artificial intelligence
Details
Download
Mobile
Exploration of the application path of real-world evidence in the reform of China's pharmaceutical regulatory system: a case study of Hainan Boao Lecheng
XIE Wansheng
CAI Lixian
LUO Wenya
TONG Yeqing
LIN Kai
LI Zhongyang
CHANG Limei
ZHAO Tuo
2026,35(3):346-354
Real-world evidence
Real-world data
Medical regulatory system
Regulatory science
Details
Download
Mobile
A case of severe multisystem adverse reactions in a multiple myeloma patient following carfilzomib
CHENG Mei
ZHAO Yun
LIU Lili
YAO Lijuan
2026,35(3):355-360
Carfilzomib
Multiple myeloma
Adverse drug reactions
Multisystem adverse reactions
Details
Download
Mobile